TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has provided an update.
Clarity Pharmaceuticals Ltd. has announced a change in substantial holding, indicating that State Street Corporation and its subsidiaries have ceased to be substantial holders in the company as of October 22, 2025. This change in holding may impact the company’s operations and market positioning, as substantial holders can influence corporate governance and strategic decisions.
The most recent analyst rating on (AU:CU6) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,467,426
Technical Sentiment Signal: Buy
Current Market Cap: A$1.8B
See more data about CU6 stock on TipRanks’ Stock Analysis page.